Generation of single chain Fv protein A fusion molecules for melanoma therapy
The high incidence rate and absence of a suitable treatment pose a great threat for melanoma patients. Surgery, the main form of treatment for clinically detectable melanoma is unsuitable for micrometastatic disease. Therefore there is a clear need for the development of new adjuvant therapies. We h...
Main Author: | Sharma, Vandana |
---|---|
Published: |
University College London (University of London)
2006
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.435053 |
Similar Items
-
Characterisation of two anti-tumour single-chain Fv-interleukin-2 fusion proteins and investigation of their immunotherapeutic potential
by: Boleti, Ekaterini
Published: (2002) -
Inhibition of Breast Cancer Metastasis and Angiogenesis by Antiosteopontin Single-Chain Fv-Fc Fusion Protein
by: Ling Peng, et al.
Published: (2009-05-01) -
Production and characterization of a single-chain Fv antibody–alkaline phosphatase fusion protein specific for ampicillin
by: Kuo He, et al.
Published: (2019-01-01) -
A human monoclonal anti-melanoma single chain Fv (scFv) antibody derived from tumor-infiltrating B lymphocytes.
by: Zhang, Hua.
Published: (1995) -
Studies of Fv1 binding and restriction
by: Li, H. L. W.
Published: (2015)